IL34 and neoplasm: Baghdadi et al. demonstrated that Interleukin 34 (IL34) was produced by cancer cells under chemotherapy-induced stress to enhance local immunosuppression of tumor-associated macrophages (TAMs), increasing the ability of cancer cells to evade an immune response (Baghdadi et al., 2016).